CNTX - CIK 0001842952
The table below shows Context Therapeutics Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $7.85M | $7.22M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $7.29M |
| $7.79M |
| $3.63M |
| $930.67K |
| Operating income | -$39.70M | -$29.92M | -$25.07M | -$15.38M | -$10.53M | -$2.57M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$36.12M | -$26.73M | -$23.96M | -$14.84M | -$10.46M | $6.64M |
| EPS (diluted) | -$0.38 | -$0.46 | -$1.50 | -$0.93 | -$3.69 | -$3.96 |